Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Pharmasset inks collaborative deal with J & J unit to develop hep C combo drugProactive Investors USA & CanadaPharmasset (NASDAQ:VRUS) reported Wednesday it signed a collaboration agreement with pharmaceutical company Tibotec, a & (NYSE:JNJ) unit, to conduct clinical trials to develop an all-oral treatment for hepatitis C. The study, ...See all stories on this topic »

Medco to Better Tackle Hepatitis CZacks.comMedco Health Solutions (MHS - Analyst Report) is making attempts to curtail costs of treating patients suffering from hepatitis C (HCV). The company's specialty pharmacy segment, Accredo Health Group, considers patient adherence to the treatment most ...See all stories on this topic »

Universal screening for hepatitis C supported by patientsHemOncTodayPatients with hepatitis C support universal screening for the disease, even if the testing is conducted without patient consent, according to researchers from the University of Washington in Seattle. In the United States, there are 2.9 million to 3.7 ...See all stories on this topic »

Pharmasset to collaborate on a safer, simpler hepatitis C drug; CytRx touts ...FierceBiotechItem | Follow @CFierce > Pharmasset has forged a collaboration pact with Tibotec Pharmaceuticals, agreeing to evaluate the safety and efficacy of a combined product for hepatitis C in a mid-stage study. Pharmasset release > CytRx reports that its ...See all stories on this topic »

New hep C therapyGastroenterology UpdateA new drug for hepatitis C significantly improves response rates when added to standard treatment, research finds. The study of 1000 hepatitis C patients found up to 75% of patients who received telaprevir (Incivek) plus peginterferon-ribavirin had a ...See all stories on this topic »

Woman with disease charged with assaultphillyBurbs.comPERKASIE — Lin struggled with officers attempting to arrest her on a public drunkenness charge, spit repeatedly in one officer's face and laughed, "I have Hepatitis C, ha, ha," according to court records. ...See all stories on this topic »

Anadys Pharma - Will It Script A Turnaround?RTT News(RTTNews) - Shares of hepatitis C drug developer Anadys Pharmaceuticals Inc. (ANDS: News ) have lost over 20 percent in the past three months and now trade for a little less than a dollar. There are a couple of catalysts to watch out for in the coming ...See all stories on this topic »

RTT News

Medco Health Solutions (NYSE:MHS) Cuts Treatment CostStocksandShares.TVMedco Health Solutions (NYSE:MHS)'s Specialty Pharmacy, Accredo Health Group Inc., has improved Hepatitis C patient outcomes and reduced treatment costs by an average $13000 per patient. Medco Health Solutions (NYSE:MHS)'s Accredo's high-touch care ...See all stories on this topic »

BioPlus Expands Executive Team with New Vice President of SalesDigitalJournal.com (press release)BioPlus is excited to have his leadership as we launch our new Best in Class therapy programs in intravenous immunoglobulin (IVIG), oncology, hepatitis C, and hemophilia,†states Gay, Chief Strategic Officer at BioPlus. ...See all stories on this topic »